09.08.2022 15:00:47
|
HCA Healthcare Signs Strategic Collaboration With Johnson & Johnson
(RTTNews) - HCA Healthcare, Inc. (HCA), Thursday announced a collaboration with Johnson & Johnson (JNJ) to improve health equity, enhance nursing support, and improve patient outcomes.
As per the agreement, Nashville-based HCA Healthcare and Johnson & Johnson will collaborate on a strategic partnership for a scalable program for the early identification of lung cancer in the Black community.
The two companies will work together on healthcare educational programming, training, and other programs that elevate and support nurses with experience and skillsets. HCA Healthcare has more than 93,000 nurses, 182 hospitals, and approximately 2,300 ambulatory sites of care in its system.
HCA Healthcare Research Institute and Johnson & Johnson will collaborate on cardiovascular health initiatives also. A retrospective analysis will be done on patients who suffer from heart arrhythmia, and also on the role of digital health technology in clinical outcomes for patients with Coronary Artery Disease, and Peripheral Artery Disease diseases.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
17.01.25 |
Börse New York: Dow Jones letztendlich im Plus (finanzen.at) | |
17.01.25 |
Gewinne in New York: Dow Jones bewegt sich nachmittags im Plus (finanzen.at) | |
17.01.25 |
Dow Jones aktuell: Dow Jones notiert am Mittag im Plus (finanzen.at) | |
17.01.25 |
NYSE-Handel: Dow Jones zum Start fester (finanzen.at) | |
16.01.25 |
Schwache Performance in New York: Dow Jones schlussendlich schwächer (finanzen.at) | |
16.01.25 |
Dow Jones-Handel aktuell: Dow Jones in der Verlustzone (finanzen.at) | |
16.01.25 |
NYSE-Handel: So performt der Dow Jones am Mittag (finanzen.at) | |
15.01.25 |
Dow Jones 30 Industrial-Titel Johnson Johnson-Aktie: So viel hätten Anleger mit einem Investment in Johnson Johnson von vor einem Jahr verloren (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
HCA Holdings Inc. | 305,50 | 2,62% | |
Johnson & Johnson | 141,64 | -0,42% |